Bicara Therapeutics BCAX
NASDAQ BCAX
$18.35 +0.00 (+0.00%)
As of: Oct 21, 2026 · 12:51 PM EDT

Bicara Therapeutics (BCAX) Common Stock Issued (2024 - 2026)

Updated

Analysis

Bicara Therapeutics (BCAX) Common Stock Issued (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Issued (Qtr)
1 Eli Lilly 1,132.21 Bn 1,100.80 Bn 19.71 Bn -
2 Johnson & Johnson 616.27 Bn 534.80 Bn 17.26 Bn 359.00 Mn
3 AbbVie 500.10 Bn 473.21 Bn 12.70 Bn -
4 Merck 366.86 Bn 321.23 Bn 12.21 Bn 43.00 Mn
5 Novartis Ag 297.92 Bn 261.91 Bn 11.24 Bn -
6 Astrazeneca 261.53 Bn 235.22 Bn 12.86 Bn 6.00 Mn
7 Amgen 234.99 Bn 190.39 Bn 7.24 Bn -
8 Gilead Sciences 190.14 Bn 164.34 Bn 6.22 Bn 9.00 Mn
9 Pfizer 169.63 Bn 116.28 Bn 10.94 Bn -
10 Bicara Therapeutics 1.24 Bn -497.58 Mn - 2.33 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.33 Mn
Mar 31, 2026 163.35 Mn
Dec 31, 2025 31.23 Mn
Sep 30, 2025 436,000.00
Jun 30, 2025 135,000.00
Mar 31, 2025 460,000.00
Dec 31, 2024 -975,000.00
Sep 30, 2024 333.54 Mn
Jun 30, 2024 1.33 Mn
Mar 31, 2024 137,000.00
API Access

Bicara Therapeutics Common Stock Issued API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-stock-issued&ticker=BCAX&period=max&api_key=YOUR_API_KEY